Reinnervate today announced the launch of a low-cost, simple system for combining 3D cell culture with dynamic circulation and perfusion of media.
This product allows scientists to create cell based models that are another step closer to the environment experienced by cells and tissue in vivo. The systems can also be used to create complex co-cultures, multi-organ systems and to study paracrine effects.
The Alvetex perfusion system is compatible with the following methods:
Note: Reinnervate Ltd (County Durham, England) was acquired by REPROCELL Inc (Yokohama, Japan) in August 2014. Biopta Ltd (Glasgow, Scotland) was acquired by REPROCELL in November 2015. REPROCELL Europe Ltd was established by merging Reinnervate and Biopta in June 2016.
Contact REPROCELL Global
Connect with our expert scientists and sales teams worldwide. We will figure out who's best to reply to you.
US Sales Inquiries
EU Sales Inquiries
India Sales Inquiries